Jing Lou
Chief Executive Officer presso 3SBIO INC.
Patrimonio netto: 483 M $ in data 31/03/2024
Profilo
Il Dr. Jing Lou è presidente della Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., presidente della Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd., presidente della Collected Mind Ltd., presidente della Taizhou Huan Sheng Investment Management Co., Ltd., amministratore delegato, direttore esecutivo e GM della Liaoning Sunshine Science & Technology Development Co. Ltd., direttore generale e amministratore presso la Liaoning Sunshine Bio-Pharmaceutical Co., Ltd., presidente e direttore-ricerca e sviluppo presso la Shenyang Sunshine Pharmaceutical Co., Ltd., presidente, presidente e amministratore delegato presso la 3SBio, Inc., presidente della Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd., presidente della Guangdong Sunshine Pharmaceutical Co., Ltd. e presidente della Shanghai Xingsheng Pharmaceutical Co. Fa parte del consiglio di amministrazione di Ample Harvest Investments Ltd., Excel Partner Holdings Ltd., Shanghai Aoxi Technology Information Consulting Co., Ltd., Shenzhen Baishitong Technology Development Co., Ltd., Zhejiang Sunshine Pharmaceutical Co., Ltd., Hong Kong Sansheng Ltd., Hongkong Sansheng Medical Ltd., Liaoning Sunshine Science & Technology Development Co. Ltd., Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. e Strategic International Group Ltd. Il Dr. Lou è stato anche membro del consiglio di amministrazione di Isotechnika Pharma, Inc. Si è laureato presso la Second Medical University di Shanghai, ha conseguito un MBA presso la China Europe International Business School e un dottorato presso la Fordham University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
3SBIO, INC.
21.65% | 21/07/2023 | 527 983 001 ( 21.65% ) | 403 M $ | 31/03/2024 |
16/01/2024 | 25 160 657 ( 4.80% ) | 80 M $ | 31/03/2024 |
Posizioni attive di Jing Lou
Società | Posizione | Inizio |
---|---|---|
3SBIO INC. | Chief Executive Officer | 01/01/2006 |
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Chairman | 01/03/2016 |
Shanghai Aoxi Technology Information Consulting Co., Ltd. | Director/Board Member | 01/12/2014 |
Full Gain Pharmaceutical Ltd. | Director/Board Member | - |
Guangdong Sunshine Pharmaceutical Co., Ltd.
Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The private company is based in Dongguan, China. | Chairman | - |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Director/Board Member | 01/11/2009 |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China. | Chairman | - |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Chairman | 01/09/1995 |
Ample Harvest Investments Ltd.
Ample Harvest Investments Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Ample Harvest Investments Ltd. provides investment services. | Director/Board Member | 01/12/2014 |
░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Jing Lou
Società | Posizione | Fine |
---|---|---|
░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Jing Lou
Fordham University | Doctorate Degree |
China Europe International Business School | Masters Business Admin |
Shanghai Second Medical University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
3SBIO INC. | Health Technology |
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
Aziende private | 19 |
---|---|
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
Hong Kong Sansheng Ltd.
Hong Kong Sansheng Ltd. Financial ConglomeratesFinance Part of Hong Kong Sansheng Group Ltd., Hong Kong Sansheng Ltd. operates as an investment holding private company. The company is based in Hong Kong, Hong Kong. | Finance |
Collected Mind Ltd.
Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company. | Finance |
Excel Partner Holdings Ltd.
Excel Partner Holdings Ltd. MiscellaneousMiscellaneous Part of 3SBio, Inc., Excel Partner Holdings Ltd. operates as a holding Chinese company. The private company is based in Hong Kong, Hong Kong. Excel Partner Holdings was acquired by 3SBio, Inc. from First Shanghai Investments Ltd. on December 31, 2014 for $25.25 million. | Miscellaneous |
Shenzhen Baishitong Technology Development Co., Ltd. | |
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Zhejiang Sunshine Pharmaceutical Co., Ltd. is a private company that manufactures pharmaceutical products. The company is based in Zhejiang, China. | Health Technology |
Shanghai Aoxi Technology Information Consulting Co., Ltd. | |
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and operation of new bioengineered drugs, genetically engineered vaccines, new pharmaceutical preparations, purified water, and distilled water. The company was founded on March 22, 1999 and is headquartered in Shenzhen, China. | Health Technology |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The private company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Health Technology |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
Ample Harvest Investments Ltd.
Ample Harvest Investments Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Ample Harvest Investments Ltd. provides investment services. | Finance |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Health Technology |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China. | Finance |
Strategic International Group Ltd.
Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Commercial Services |
Shanghai National Engineering Research Center of Antibody Medi | |
Guangdong Sunshine Pharmaceutical Co., Ltd.
Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The private company is based in Dongguan, China. | Health Technology |
Full Gain Pharmaceutical Ltd. | |
Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | |
Liaoning Sunshine Science & Technology Development Co. Ltd. |
- Borsa valori
- Insiders
- Jing Lou